Margalit A - Search Results

1

Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40.

Levin N, Pato A, Cafri G, Eisenberg G, Peretz T, Margalit A, Lotem M, Gross G. Levin N, et al. Among authors: margalit a. J Immunother. 2017 Feb/Mar;40(2):39-50. doi: 10.1097/CJI.0000000000000150. J Immunother. 2017. PMID: 28005579

2

Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells.

Pato A, Eisenberg G, Machlenkin A, Margalit A, Cafri G, Frankenburg S, Merims S, Peretz T, Lotem M, Gross G. Pato A, et al. Among authors: margalit a. Clin Exp Immunol. 2015 Nov;182(2):220-9. doi: 10.1111/cei.12688. Epub 2015 Aug 28. Clin Exp Immunol. 2015. PMID: 26212048 Free PMC article.

3

Membrane-attached Cytokines Expressed by mRNA Electroporation Act as Potent T-Cell Adjuvants.

Weinstein-Marom H, Pato A, Levin N, Susid K, Itzhaki O, Besser MJ, Peretz T, Margalit A, Lotem M, Gross G. Weinstein-Marom H, et al. Among authors: margalit a. J Immunother. 2016 Feb-Mar;39(2):60-70. doi: 10.1097/CJI.0000000000000109. J Immunother. 2016. PMID: 26849075

4

Targeting tumor-associated antigens to the MHC class I presentation pathway.

Gross G, Margalit A. Gross G, et al. Among authors: margalit a. Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):99-109. doi: 10.2174/187153007780832064. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 17584150 Review.

5

Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.

Berko D, Carmi Y, Cafri G, Ben-Zaken S, Sheikhet HM, Tzehoval E, Eisenbach L, Margalit A, Gross G. Berko D, et al. Among authors: margalit a. J Immunol. 2005 Feb 15;174(4):2116-23. doi: 10.4049/jimmunol.174.4.2116. J Immunol. 2005. PMID: 15699142

6

Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene.

Cafri G, Amram E, Rinott G, Koifman G, Fishman S, Keisari Y, Tzehoval E, Margalit A, Eisenbach L, Gross G. Cafri G, et al. Among authors: margalit a. Int Immunol. 2011 Jul;23(7):453-61. doi: 10.1093/intimm/dxr033. Epub 2011 Jun 7. Int Immunol. 2011. PMID: 21652516

7

Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulin.

Cafri G, Margalit A, Tzehoval E, Eisenbach L, Gross G. Cafri G, et al. Among authors: margalit a. Ann N Y Acad Sci. 2013 Apr;1283:87-90. doi: 10.1111/nyas.12017. Epub 2013 Feb 6. Ann N Y Acad Sci. 2013. PMID: 23387369 Review.

8

mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity.

Cafri G, Sharbi-Yunger A, Tzehoval E, Alteber Z, Gross T, Vadai E, Margalit A, Gross G, Eisenbach L. Cafri G, et al. Among authors: margalit a. Mol Ther. 2015 Aug;23(8):1391-1400. doi: 10.1038/mt.2015.90. Epub 2015 May 22. Mol Ther. 2015. PMID: 25997427 Free PMC article.

9

Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.

Perez S, Fishman S, Bordowitz A, Margalit A, Wong FS, Gross G. Perez S, et al. Among authors: margalit a. Immunology. 2014 Dec;143(4):609-17. doi: 10.1111/imm.12340. Immunology. 2014. PMID: 24943731 Free PMC article.

10

Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.

Margalit A, Fishman S, Berko D, Engberg J, Gross G. Margalit A, et al. Int Immunol. 2003 Nov;15(11):1379-87. doi: 10.1093/intimm/dxg136. Int Immunol. 2003. PMID: 14565936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters